Gene · 2173
FABP7: fatty acid binding protein 7
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FABP7: fatty acid binding protein 7. Genes, record 2173. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2173
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O15540 | Fatty acid-binding protein, brain | 132 | 9 | Ensembl, GeneID, HGNC |
Source UniProt
Patents48
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 45933 | O15540 | Espacenet |
| EP 4487869 A2 | 2025-01-08 | 167 | O15540 | Espacenet |
| US 11998540 B2 | 2024-06-04 | 3 | O15540 | Espacenet |
| KR 1020240027895 A | 2024-03-04 | 359 | O15540 | Espacenet |
| KR 1020230143958 A | 2023-10-13 | 42 | O15540 | Espacenet |
| JP 2023036863 A | 2023-03-14 | 359 | O15540 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 30870 | O15540 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 133841 | O15540 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 3766 | O15540 | Espacenet |
| US 10918740 B2 | 2021-02-16 | 1525 | O15540 | Espacenet |
1 to 10 of 48
See all 48 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,563
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FABP7 papers | Newest fiscal year |
|---|---|---|---|
| R01DK030292 | Genomic and metabolomic foundations of human-microbial symbiosis in the gut | 40 | 2025 |
| R01DK038389 | Lipid transport in the intestine | 27 | 2025 |
| P01CA096832 | NORMAL & NEOPLASTIC GROWTH IN THE BRAIN | 12 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 9 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 9 | 2025 |
| R01NS028840 | Mitogenic Activities in Neurofibromatosis | 6 | 2025 |
| P30DK026743 | UCSF Liver Center | 5 | 2025 |
| P30DK052574 | Host-environment interactions in the pathophysiology of digestive disease | 5 | 2025 |
| R01CA159859 | Dysregulation of the Core Binding Factor Complex Inhibits Differentiation and Drives Group 4 Medulloblastoma | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,563Source NIH's project files
See all 1,563 nih grantsPapers2,926
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fatty Acid-Binding Proteins and Substance Use Disorders: From Lipid Signaling to Therapeutic Targets. | Genes (Basel) | 2026 | 42792895 | PubTator, text mining | PubMed |
| Nuclear distribution element-like 1 is associated with dentate gyrus remodeling after status epilepticus in a pilocarpine-induced mouse model. | Neuroscience | 2026 | 42595210 | PubTator, text mining | PubMed |
| hsa-miR-9-FABP7 axis as a predictive biomarker for metastatic progression in triple-negative breast cancer: An integrated analysis. | Biochem Biophys Res Commun | 2026 | 42501559 | PubTator, text mining | PubMed |
| FABP7: A Regulator of Neuro-Immune Metabolic Networks and Therapeutic Vulnerabilities in Glioma. | Cancers (Basel) | 2026 | 42449574 | PubTator, text mining | PubMed |
| Perfluorooctanoic acid (PFOA) induces lipid accumulation, oxidative stress, and reduced neurogenesis in primary human neuronal progenitor cells. | Front Toxicol | 2026 | 42221361 | PubTator, text mining | PubMed |
| A human corticospinal organoid-slice connectoid model informs enhancer strategies for post-injury axon regrowth. | Cell Rep | 2026 | 42201810 | PubTator, text mining | PubMed |
| Targeting YRDC blocks codon-biased FABP7 translation and lipid droplet formation to overcome chemoresistance in glioblastoma. | Oncogene | 2026 | 42014887 | PubTator, text mining | PubMed |
| FABP7 controls radial glial scaffold stability during human cortical development. | Proc Natl Acad Sci U S A | 2026 | 41984827 | PubTator, text mining | PubMed |
| Transcriptomic Profiling Identifies a Distinct Molecular Signature in OSMF-Derived Oral Squamous Cell Carcinoma. | Life (Basel) | 2026 | 41900972 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | 41881983 | PubTator, text mining | PubMed |
1 to 10 of 2,926
See all 2,926 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2173
GET https://conductscience.org/api/genes/v1/2173/patents?page=2